Abbas Montazeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abbas Montazeri has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
H. Rafii-Tabar
Department of Medical Physics and Biomedical Engineering, Shahid Beheshti University of Medical Sciences, Evin, Tehran, Iran
6 shared publications- Behzad Mehrafrooz
Center for Computation & Theory of Soft Materials, Northwestern University, Evanston, Illinois, United States of America
5 shared publications A. Kardani
4 shared publicationsAli Yeganeh Kari
Department of Nanotechnology, Faculty of Engineering, University of Guilan, Rasht, Iran
4 shared publications- Sadollah Ebrahimi
Université de Sherbrooke
4 shared publications B. Motevalli
Department of Mechanical and Aerospace Engineering, Monash University, Clayton, Australia
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Elsevier in Results in Engineering
- Vol. 32
Enhancing rate capability and cycle life of TiNb2O7 anodes: the synergistic role of compositing with carbon nanofibers and SDS morphological tuning
- 2 November 2026
- Published by Elsevier in Results in Engineering
- Vol. 32
Open AccessEnhancing rate capability and cycle life of TiNb2O7 anodes: the synergistic role of compositing with carbon nanofibers and SDS morphological tuning
- 29 October 2026
- Published by Elsevier in Applied Surface Science
- Vol. 755
Anisotropic lithium diffusion in single-crystal silicon anodes: atomic-scale insights for enhanced lithium-ion batteries
- 29 October 2026
- Published by Elsevier in Applied Surface Science
- Vol. 755
Anisotropic lithium diffusion in single-crystal silicon anodes: atomic-scale insights for enhanced lithium-ion batteries
- 20 June 2026
- Published by Springer Nature in In Silico Pharmacology
- Vol. 14 (2) , 164
Elucidating the mechanism of inhibitory action of novel macrocyclic compounds against ALK in non-small cell lung carcinoma: insight from molecular dynamics and virtual screening
Non-small cell lung carcinoma can be caused by the dysregulation, overexpression, or fusion of Anaplastic Lymphocytic Leukemia Kinase (ALK), which plays an essential part in cell growth and division. Several drugs have been tested against ALK overactivity, but their failure to interact effectively necessitates accelerated research efforts for the development of effective therapeutics targeting ALK. The aim of this investigation was to identify prospective macrocyclic compounds, defined as molecules containing a ring of 12 or more heavy atoms, with inhibitory potential against ALK using computational chemistry methods. To identify lead macrocyclic compounds, this work describes a five-site pharmacophore model (HHRRR_1) that showed the best survival score and PhaseHypoScore. To determine the active molecules and predict their IC50, a reliable 2D-QSAR model with an R2 of 0.9962 was used. Using docking techniques, the binding affinity of the most active compounds was analyzed in the next step. MD simulation was performed on the three most effective compounds-ML1, ML2, and ML3-to enable a comprehensive exploration of their complexes with ALK. The docking studies were validated by MD analysis results, demonstrating that all compounds form stable complexes with ALK. The pharmacokinetic properties of all compounds were assessed using ADME/tox properties, including absorption, distribution, metabolism, excretion, and toxicological characteristics. The present study provides insights into the design of novel macrocyclic compounds targeting ALK, which can be utilized to advance the development of innovative ALK inhibitors. The online version contains supplementary material available at 10.1007/s40203-026-00683-8.
- 20 June 2026
- Published by Springer Nature in In Silico Pharmacology
- Vol. 14 (2) , 164
Elucidating the mechanism of inhibitory action of novel macrocyclic compounds against ALK in non-small cell lung carcinoma: insight from molecular dynamics and virtual screening
Non-small cell lung carcinoma can be caused by the dysregulation, overexpression, or fusion of Anaplastic Lymphocytic Leukemia Kinase (ALK), which plays an essential part in cell growth and division. Several drugs have been tested against ALK overactivity, but their failure to interact effectively necessitates accelerated research efforts for the development of effective therapeutics targeting ALK. The aim of this investigation was to identify prospective macrocyclic compounds, defined as molecules containing a ring of 12 or more heavy atoms, with inhibitory potential against ALK using computational chemistry methods. To identify lead macrocyclic compounds, this work describes a five-site pharmacophore model (HHRRR_1) that showed the best survival score and PhaseHypoScore. To determine the active molecules and predict their IC50, a reliable 2D-QSAR model with an R2 of 0.9962 was used. Using docking techniques, the binding affinity of the most active compounds was analyzed in the next step. MD simulation was performed on the three most effective compounds-ML1, ML2, and ML3-to enable a comprehensive exploration of their complexes with ALK. The docking studies were validated by MD analysis results, demonstrating that all compounds form stable complexes with ALK. The pharmacokinetic properties of all compounds were assessed using ADME/tox properties, including absorption, distribution, metabolism, excretion, and toxicological characteristics. The present study provides insights into the design of novel macrocyclic compounds targeting ALK, which can be utilized to advance the development of innovative ALK inhibitors. The online version contains supplementary material available at 10.1007/s40203-026-00683-8.
- Open Access
- 1 May 2026
- Published by Elsevier in Composites Part C: Open Access
- Vol. 20
Synergistic reinforcement and wear mechanisms in basalt fiber–epoxy composites: Insights into the integration of hybrid nanoparticles
- 1 May 2026
- Published by Elsevier in Composites Part C: Open Access
- Vol. 20
Open AccessSynergistic reinforcement and wear mechanisms in basalt fiber–epoxy composites: Insights into the integration of hybrid nanoparticles
- 18 April 2026
- Published by Elsevier in Surfaces and Interfaces
- Vol. 92
Endcap chemistry modulates PLGA hydrophilicity and compatibility with lipid membranes
- 18 April 2026
- Published by Elsevier in Surfaces and Interfaces
- Vol. 92
Endcap chemistry modulates PLGA hydrophilicity and compatibility with lipid membranes
- Open Access
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (4) , e1014148
A biophysical model of phagocytic cup dynamics: The effect of membrane tension
Phagocytosis is a fundamental cellular process by which cells engulf external particles, controlled by receptor–ligand binding and actin-driven membrane dynamics. While a number of mathematical models have been developed to describe this process, they often overlook membrane tension, a key physical parameter known to influence membrane deformation and cytoskeletal behaviour. To address this gap, we present an enhanced mathematical model of receptor motion during phagocytosis that explicitly incorporates the role of membrane tension. Further, we introduce a signalling component that is coupled to receptor dynamics via the membrane tension. We find that including tension results in fundamentally different engulfment behaviour, which is slower than that predicted by models without tension. In particular, unlike in the previous version of this model, we show that tension can lead to stalled engulfment, an experimentally-observed phenomenon known as frustrated phagocytosis. We also find that signalling is able to modify engulfment behaviour, especially at later stages, and is able to alter cup growth to become linear in time without the need for receptor drift as introduced in previous models. These findings offer new insights into the role of membrane tension and biophysical regulation in phagocytosis, with implications for immune function, cell motility and targeted drug delivery.
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (4) , e1014148
Open AccessA biophysical model of phagocytic cup dynamics: The effect of membrane tension
Phagocytosis is a fundamental cellular process by which cells engulf external particles, controlled by receptor–ligand binding and actin-driven membrane dynamics. While a number of mathematical models have been developed to describe this process, they often overlook membrane tension, a key physical parameter known to influence membrane deformation and cytoskeletal behaviour. To address this gap, we present an enhanced mathematical model of receptor motion during phagocytosis that explicitly incorporates the role of membrane tension. Further, we introduce a signalling component that is coupled to receptor dynamics via the membrane tension. We find that including tension results in fundamentally different engulfment behaviour, which is slower than that predicted by models without tension. In particular, unlike in the previous version of this model, we show that tension can lead to stalled engulfment, an experimentally-observed phenomenon known as frustrated phagocytosis. We also find that signalling is able to modify engulfment behaviour, especially at later stages, and is able to alter cup growth to become linear in time without the need for receptor drift as introduced in previous models. These findings offer new insights into the role of membrane tension and biophysical regulation in phagocytosis, with implications for immune function, cell motility and targeted drug delivery.
- Open Access
- 8 December 2025
- Published by Elsevier in Materials & Design
- Vol. 261
From SLM process parameters to performance: microstructure and mechanics of nanostructured titanium
- 8 December 2025
- Published by Elsevier in Materials & Design
- Vol. 261
Open AccessFrom SLM process parameters to performance: microstructure and mechanics of nanostructured titanium
- Open Access
A Biophysical Model of Phagocytic Cup Dynamics: The Effect of Membrane Tension
Phagocytosis is a fundamental cellular process by which cells engulf external particles, controlled by receptor–ligand binding and actin-driven membrane dynamics. While a number of mathematical models have been developed to describe this process, they often overlook membrane tension, a key physical parameter known to influence membrane deformation and cytoskeletal behaviour. To address this gap, we present an enhanced mathematical model of receptor motion during phagocytosis that explicitly incorporates the role of membrane tension. Further, we introduce a signalling component that is coupled to receptor dynamics via the membrane tension. We find that including tension results in fundamentally different engulfment behaviour, which is slower than that predicted by models without tension. In particular, unlike in the previous version of this model, we show that tension can lead to stalled engulfment, an experimentally-observed phenomenon known as frustrated phagocytosis. We also find that signalling is able to modify engulfment behaviour, especially at later stages, and is able to alter cup growth to become linear in time without the need for receptor drift as introduced in previous models. These findings offer new insights into the role of membrane tension and biophysical regulation in phagocytosis, with implications for immune function, cell motility and targeted drug delivery.
Open AccessA Biophysical Model of Phagocytic Cup Dynamics: The Effect of Membrane Tension
Phagocytosis is a fundamental cellular process by which cells engulf external particles, controlled by receptor–ligand binding and actin-driven membrane dynamics. While a number of mathematical models have been developed to describe this process, they often overlook membrane tension, a key physical parameter known to influence membrane deformation and cytoskeletal behaviour. To address this gap, we present an enhanced mathematical model of receptor motion during phagocytosis that explicitly incorporates the role of membrane tension. Further, we introduce a signalling component that is coupled to receptor dynamics via the membrane tension. We find that including tension results in fundamentally different engulfment behaviour, which is slower than that predicted by models without tension. In particular, unlike in the previous version of this model, we show that tension can lead to stalled engulfment, an experimentally-observed phenomenon known as frustrated phagocytosis. We also find that signalling is able to modify engulfment behaviour, especially at later stages, and is able to alter cup growth to become linear in time without the need for receptor drift as introduced in previous models. These findings offer new insights into the role of membrane tension and biophysical regulation in phagocytosis, with implications for immune function, cell motility and targeted drug delivery.